GlassScriptPhysician profile
Yanira Raza
NPI 1194838904
$872.52
in general payments reported to CMS, 2019-2025
16 companies · $33.36 in 2025
The $33.36 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.48 · 2020: $150 · 2021: $124 · 2022: $103 · 2023: $230 · 2024: $139 · 2025: $33.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $339.99 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $186.72 | 2019-2023 | Farxiga |
| Boston Scientific Corporation | $61.28 | 2022-2023 | |
| Glaxosmithkline, LLC. | $57.72 | 2021-2023 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $57.51 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.62 | 2022 | |
| Merck Sharp & Dohme LLC | $17.12 | 2020 | |
| Amarin Pharma, INC. | $16.37 | 2019 | |
| Abbott Laboratories | $15.83 | 2023 | Freestyle Libre 3 |
| Exact Sciences Corporation | $15.48 | 2023 | Cologuard Collection Kit |
| Phadia US INC. | $14.95 | 2023 | Immunocap |
| Amgen INC. | $14.26 | 2019 | |
| Astellas Pharma US INC | $13.00 | 2021 | |
| Allergan, INC. | $12.86 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanira Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.